Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 19, 2021

SELL
$3.8 - $4.56 $1,900 - $2,280
-500 Reduced 71.43%
200 $0
Q1 2021

Apr 26, 2021

BUY
$4.33 - $6.63 $433 - $663
100 Added 16.67%
700 $3,000
Q4 2020

Jan 21, 2021

BUY
$4.87 - $17.29 $306 - $1,089
63 Added 11.73%
600 $3,000
Q2 2020

Jul 22, 2020

SELL
$14.57 - $23.96 $57,740 - $94,953
-3,963 Reduced 88.07%
537 $12,000
Q1 2020

May 07, 2020

BUY
$10.27 - $21.23 $29,783 - $61,567
2,900 Added 181.25%
4,500 $66,000
Q3 2019

Oct 28, 2019

BUY
$9.83 - $14.82 $983 - $1,482
100 Added 6.67%
1,600 $15,000
Q2 2019

Aug 09, 2019

BUY
$12.9 - $20.8 $17,169 - $27,684
1,331 Added 787.57%
1,500 $20,000
Q1 2019

May 10, 2019

SELL
$17.7 - $24.93 $131,528 - $185,254
-7,431 Reduced 97.78%
169 $3,000
Q4 2018

Feb 05, 2019

BUY
$19.05 - $36.45 $140,970 - $269,730
7,400 Added 3700.0%
7,600 $171,000
Q3 2018

Nov 07, 2018

SELL
$34.41 - $44.23 $66,273 - $85,186
-1,926 Reduced 90.59%
200 $7,000
Q2 2018

Aug 10, 2018

SELL
$39.21 - $50.29 $88,340 - $113,303
-2,253 Reduced 51.45%
2,126 $83,000
Q3 2017

Oct 17, 2017

BUY
$23.08 - $34.92 $101,067 - $152,914
4,379
4,379 $152,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $723M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.